Published:

J Dermatolog Treat. 2015 Oct;26(5):426-30. doi: 10.3109/09546634.2015.1021238. Epub 2015 Apr 20.

Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.

Yonit Bomstein PhD, Sharon Rozenblat PhD.

Objective:

Efficacy evaluation of TOPIC SKIN Face & Body Cream for treating Atopic Dermatitis in children

Results:

• 57.3% Improvement in SCORAD (scoring Atopic Dermatitis)
• 38.6% Improvement in EASI (Eczema Area Severity Index) within 2 weeks
• Continuous improvement, 63.6% within 6 weeks
• 100% Satisfaction with the treatment
• 95.7% Trunk improvement vs. control
• No adverse events

Before & After:

Graphs